Form 4 for BKYI BIO KEY INTERNATIONAL INC
Accepted 2023-09-18 00:00:00 ET · period of report 2023-09-15 · accession 0001437749-23-026164 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-09-18 | 2023-09-15 | BKYI | Sullivan James David | CLO, SVP Strategy, Compliance | P - Purchase | $0.5496 | +5,000 | 130.5K | +4% | +$2,748 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-09-15 | P | A | 96 | $0.53 | 125,596 | D | — | — | (F1) Holdings do not include options to purchase 18,750 shares. |
| 2 | Common | Common Stock | 2023-09-15 | P | A | 4,904 | $0.55 | 130,500 | D | — | — | (F1) Holdings do not include options to purchase 18,750 shares. |